DSpace logo
Please use this identifier to cite or link to this item: http://172.20.40.131:8080/jspui/handle/123456789/3508
Title: Current Treatment Options Available for COVID-19 : A Review
Authors: Mehta, Maulin
Patharkar, Jayant
Keywords: Convalescent Plasma Therapy
Corona-Virus Disease (COVID)-19
Hydroxychloroquine
Remdesivir
Tocilizumab
Vaccine
Issue Date: 2020
Publisher: Asian Journal of Pharmaceutical Research and Health Care
Abstract: The World Health Organization (WHO) introduced the term 2019 novel corona virus to refer to a corona virus that affected the lower respiratory tract of patients with pneumonia in Wuhan, China. The official name of the 2019 novel corona virus is corona virus disease (COVID-19), announced by WHO. The total reported cases of COVID-19 as of 15th June, 2020 are 79,95,877 and 4,35,598 reported deaths. Non-availability of vaccines and medicines for its treatment is really threatening to the world right now. All chloroquine and Hydroxychloroquine, antibacterial therapy like azithromycin and doxycycline, antiviral therapy like lopinavir/ritonavir and remdesivir, convalescent plasma therapy, zinc, vaccines and Tocilizumab are part of possible management options and none is officially approved for the treatment. Current review of various articles by searching on PubMed is initiated with intention of creating meaningful information regarding all possible management that is available or will be available in near future of COVID-19.
URI: http://172.20.40.131:80/jspui/handle/123456789/3508
ISSN: 2250-1444
Appears in Collections:Faculty Publications

Files in This Item:
File Description SizeFormat 
Current Treatment Options Available for COVID-19 A Review.docx13.72 kBMicrosoft Word XMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.